Ascelia Pharma AB (publ)

OM:ACE Stock Report

Market Cap: SEK 256.1m

Ascelia Pharma Balance Sheet Health

Financial Health criteria checks 4/6

Ascelia Pharma has a total shareholder equity of SEK107.6M and total debt of SEK26.2M, which brings its debt-to-equity ratio to 24.4%. Its total assets and total liabilities are SEK161.4M and SEK53.8M respectively.

Key information

24.4%

Debt to equity ratio

SEK 26.22m

Debt

Interest coverage ration/a
CashSEK 95.72m
EquitySEK 107.58m
Total liabilitiesSEK 53.83m
Total assetsSEK 161.41m

Recent financial health updates

Recent updates

Health Check: How Prudently Does Ascelia Pharma (STO:ACE) Use Debt?

Nov 09
Health Check: How Prudently Does Ascelia Pharma (STO:ACE) Use Debt?

Is Ascelia Pharma (STO:ACE) Using Debt In A Risky Way?

May 31
Is Ascelia Pharma (STO:ACE) Using Debt In A Risky Way?

Is Ascelia Pharma (STO:ACE) In A Good Position To Invest In Growth?

May 11
Is Ascelia Pharma (STO:ACE) In A Good Position To Invest In Growth?

Ascelia Pharma (STO:ACE) Is In A Good Position To Deliver On Growth Plans

Aug 05
Ascelia Pharma (STO:ACE) Is In A Good Position To Deliver On Growth Plans

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Jan 24
We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Aug 23
We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Companies Like Ascelia Pharma (STO:ACE) Are In A Position To Invest In Growth

May 19
Companies Like Ascelia Pharma (STO:ACE) Are In A Position To Invest In Growth

Here's What Ascelia Pharma AB (publ)'s (STO:ACE) Shareholder Ownership Structure Looks Like

Mar 07
Here's What Ascelia Pharma AB (publ)'s (STO:ACE) Shareholder Ownership Structure Looks Like

Helena Wennerström Is The Independent Director of Ascelia Pharma AB (publ) (STO:ACE) And They Just Picked Up 125% More Shares

Dec 09
Helena Wennerström Is The Independent Director of Ascelia Pharma AB (publ) (STO:ACE) And They Just Picked Up 125% More Shares

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Nov 26
We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Financial Position Analysis

Short Term Liabilities: ACE's short term assets (SEK104.0M) exceed its short term liabilities (SEK27.6M).

Long Term Liabilities: ACE's short term assets (SEK104.0M) exceed its long term liabilities (SEK26.2M).


Debt to Equity History and Analysis

Debt Level: ACE has more cash than its total debt.

Reducing Debt: ACE's debt to equity ratio has increased from 0% to 24.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ACE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ACE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies